# US 2024/0002806 A1 · Method for differentiating adult stem cells into final tissue

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002806 A1
- Document ID: US20240002806A1
- Status: Published application
- Kind: A1
- Application number: 18/119,314
- Filed: 2023-03-09
- Published: 2024-01-04
- Earliest claimed: 2022-03-10
- Assignees: Innocent Meat GmbH
- Applicants: Innocent Meat GMBH
- Inventors: Patrick Nonnenmacher
- Web page: https://patentgrep.com/patent/US20240002806A1

## CPC

- C12N 5/0658: {Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts}
- A23J 3/04: Animal proteins
- A23J 3/227: {Meat-like textured foods (meat extenders A23L13/00)}
- A23L 13/00: Meat products; Meat meal; Preparation or treatment thereof
- C07K 14/005: from viruses
- C12N 5/0653: {Adipocytes; Adipose tissue}
- C07K 2319/10: containing a tag for extracellular membrane crossing, e.g. TAT or VP22
- C07K 2319/21: containing a His-tag
- C12N 2501/998: Proteins not provided for elsewhere
- C12N 2506/1323: from skeletal muscle cells
- C12N 2506/1346: from mesenchymal stem cells
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N 2510/00: Genetically modified cells
- C12N 2740/16322: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23J: PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

A method for differentiating adult stem cells into a final tissue is described. The method utilizes adult stem cells as a primary material for cultivation of fat and muscle tissue, resulting in an easier induction potential to differentiate into the target cells. To induce the differentiation, transcription factors are used.

## Claims

### Claim 1

A method comprising:
utilizing a transcription factor to induce differentiation of adult stem cells induced pluripotent stem cells (IPSC) into myocytes or adipocytes; and
applying the myocytes and/or the adipocytes to a cell culture process via addition into a culture medium.

### Claim 2 (depends on 1)

The method of claim 1, wherein the adult stem cells comprise satellite cells and mesenchymal stem cells.

### Claim 3 (depends on 1)

The method of claim 1, wherein the transcription factor comprises a muscle-inducing peptide/protein or a fat-inducing peptide/protein.

### Claim 4 (depends on 3)

The method of claim 3, wherein the muscle-inducing peptide/protein is one or more members selected from the group consisting of: PAX-7, Myf5, MyoD1 and Myogenin.

### Claim 5 (depends on 3)

The method of claim 3,
wherein the muscle-inducing peptide/protein comprises the MyoD1, and
wherein the method further comprises: engaging in post-translational modification of the MyoD1.

### Claim 6 (depends on 3)

The method of claim 3, wherein the fat-inducing peptide/protein is one or more members selected from the group consisting of: Pref-1, PPAR-γ, and C/EBPα.

### Claim 7 (depends on 3)

The method of claim 3,
wherein the fat-inducing peptide/protein comprises the C/EBPα, and
wherein the method further comprises: engaging in post-translational modification of the C/EBPα.

### Claim 8 (depends on 3)

The method of claim 3, further comprising:
modifying the muscle-inducing peptide/protein or the fat-inducing peptide/protein with a cell penetrating peptide.

### Claim 9 (depends on 8)

The method of claim 8, wherein the cell penetrating peptide comprises a trans-activator of transcription (TAT) signal peptide.

### Claim 10 (depends on 8)

The method of claim 8, wherein the muscle-inducing peptide/protein and/or the fat-inducing peptide/protein is transcribed and translated from a DNA fusion protein gene sequence that comprises a gene sequence for the muscle-inducing peptide/protein or the fat-inducing peptide/protein and a gene sequence for the cell penetrating peptide.

### Claim 11 (depends on 10)

The method of claim 10, wherein the DNA fusion protein gene sequence further comprises a linker DNA sequence and/or a purifying peptide gene sequence.

### Claim 12 (depends on 11)

The method of claim 11, wherein the fusion protein gene sequence comprises a linker DNA sequence and a purifying peptide gene sequence.

### Claim 13 (depends on 12)

The method of claim 12, wherein the fusion protein gene sequence comprises one or more gene sequences selected from the group consisting of gene sequences that encode PAX-7, Myf5, MyoD1, Myogenin, Pref-1, PPAR-γ, C/EBPα, and TAT.

### Claim 14 (depends on 12)

The method of claim 12, wherein the purifying peptide gene sequence is a his tag.

### Claim 15 (depends on 3)

The method of claim 3, wherein the method further comprises adding supplemental ingredients to the cell culture process.

### Claim 16 (depends on 15)

The method of claim 15, wherein the supplemental ingredients comprise one or more of unsaturated fatty acids, surfactants, lipids, polyphenols, or other small molecules.

### Claim 17 (depends on 16)

The method of claim 16, wherein the supplemental ingredients are one or more members selected from the group consisting of Erucic acid, Elaidic acid, Oleic Acid, Palmitoleic acid, Myristoleic acid, Phytanic acid, Pristanic acid, linoleic acid, albumins, putrescine, spermine, Lysophosphatidic acid (LPA), Epicatechine, Trichostatin A, and PD 98,059.

### Claim 18 (depends on 1)

The method of claim 1, wherein the myocytes and/or the adipocytes comprise a cell line that is used to create a cultured, clean meat, or in vitro meat product.

### Claim 19

A meat product made by a method of utilizing a transcription factor to induce differentiation of induced pluripotent stem cells (IPSC) adult stem cells into myocytes or adipocytes; and
applying the myocytes and/or the adipocytes to a cell culture process via addition into a culture medium, wherein the cell culture process is a process to generate a meat product.

### Claim 20 (depends on 19)

The meat product of claim 19, wherein the transcription factor is a fusion protein that further comprises a cell penetrating peptide, and optionally comprises a linker segment and a purification segment.
